Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs
DEC 15 (Reuters) – A federal judicial panel said Monday it would centralize a growing number of lawsuits…
UK pledges extra $2 billion NHS spend to avert Trump tariffs, FT says
Dec 11 (Reuters) – Britain has promised the United States that spending on National Health Service (NHS) medicines…
UK medicine rebate rate to drop in 2026 after US pharma deal
Item 1 of 2 Unused and expired medications, including pills, tablets and capsules, collected for disposal to prevent…
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…
US slashes 36% off Medicare spending on 15 high-priced medicines
Medicare says negotiated prices for 15 drugs to cut spending by 36% New prices to take effect in…
Denmark compensates patients for vision loss linked to Novo Nordisk drugs
COPENHAGEN, Nov 21 (Reuters) – Four patients in Denmark, who experienced vision loss after using Novo Nordisk’s (NOVOb.CO),…
J&J expands cancer portfolio with $3.05 billion Halda buy
Nov 17 (Reuters) – Johnson & Johnson (JNJ.N), opens new tab said on Monday it would buy privately…
Swiss machine maker feels heat from auto sector slowdown, Trump’s tariffs
Swiss machine maker lays off staff after US tariffs Pfiffner already struggling due to car industry woes Weak…
Switzerland wins US tariff rate cut to 15%, pledges $200 billion in US investments
Swiss government says US tariff rate to fall to 15% from 39% US trade chief Greer says Switzerland…
Texas judge in Tylenol case won’t block Kenvue’s $398 million dividend payment, lawyer says
Company has scheduled dividend payment for November 26 Paxton said Kenvue concealed Tylenol’s risks to kids when taken…
Lower prices mean more Americans can start weight-loss drugs, doctors say
Trump administration deal cuts prices for GLP-1 weight-loss drugs Medicare patients see expanded eligibility and capped costs Concerns…
US FDA awards six more fast-track vouchers to speed drug reviews
Nov 6 (Reuters) – The U.S. Food and Drug Administration said on Thursday it has awarded six more…